每經AI快(kuai)訊，12月4日，恒瑞醫藥公(gong)(gong)(gong)告(gao)(gao)，近日，公(gong)(gong)(gong)司(si)董(dong)事(shi)會收到(dao)公(gong)(gong)(gong)司(si)副總經理、首席(xi)醫學執行(xing)(xing)官（腫瘤）張(zhang)曉靜(jing)的(de)(de)辭(ci)職(zhi)(zhi)(zhi)報告(gao)(gao)。張(zhang)曉靜(jing)因(yin)個人原因(yin)申請辭(ci)去(qu)公(gong)(gong)(gong)司(si)副總經理、首席(xi)醫學執行(xing)(xing)官（腫瘤）職(zhi)(zhi)(zhi)務，辭(ci)職(zhi)(zhi)(zhi)報告(gao)(gao)自送達公(gong)(gong)(gong)司(si)董(dong)事(shi)會之日起生效(xiao)。辭(ci)去(qu)上述職(zhi)(zhi)(zhi)務后(hou)，張(zhang)曉靜(jing)不再(zai)擔任公(gong)(gong)(gong)司(si)任何(he)職(zhi)(zhi)(zhi)務，其負責的(de)(de)相關工作已進(jin)行(xing)(xing)交接，本次人事(shi)變動不會影響公(gong)(gong)(gong)司(si)相關工作的(de)(de)正常開展。